Sponsor-Patient Interactions: Establishing Consensus on Good Practices for Patient Engagement in Drug Development

The National Health Council (NHC), in partnership with the Genetic Alliance (GA) and Food and Drug Law Institute (FDLI), is hosting a conference on good practices for sponsor-patient interactions as part of achieving meaningful patient engagement in drug development with a goal of establishing recommendations to inform company and patient advocacy group policy.

The conference, Sponsor-Patient Interactions: Establishing Consensus on Good Practices for Patient Engagement in Drug Development, will be held on Thursday, June 15 in Washington, DC, at the Capital Hilton (1001 16th Street NW, Washington, DC 20036. Federal AB room) from 10:00 a.m. to 4:00 p.m.

Learn More